Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 4 (2007), Issue 11 (November)

1. Gingival infiltration in acute monoblastic leukaemia.
   Br Dent J, 203(9): 507-9. [Abstract] [Full-text]
2. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice.
   Cancer Res, 67(22): 10677-85. [Abstract] [Full-text]
3. Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants.
   J Pharmacol Exp Ther, 323(3): 935-45. [Abstract] [Full-text]
4. Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia.
   Bone Marrow Transplant, 40(11): 1069-74. [Abstract] [Full-text]
5. Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
   Bone Marrow Transplant, 40(11): 1027-32. [Abstract] [Full-text]
6. The expression of cytosolic phospholipase A2 and biosynthesis of leukotriene B4 in acute myeloid leukemia cells.
   Eur J Haematol, 79(6): 468-76. [Abstract] [Full-text]
7. The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.
   Blood, 110(12): 4073-6. [Abstract] [Full-text]
8. Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.
   Leukemia, 21(12): 2406-10. [Abstract] [Full-text]
9. Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia.
   Leukemia, 21(12): 2495-505. [Abstract] [Full-text]
10. Expression of components of the IGF axis in childhood acute myelogenous leukemia.
    Pediatr Blood Cancer, 50(1): 24-8. [Abstract] [Full-text]
11. Toxicity and outcome of children with treatment related acute myeloid leukemia.
    Pediatr Blood Cancer, 50(1): 17-23. [Abstract] [Full-text]
12. Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.
    Pediatr Blood Cancer, 50(1): 9-16. [Abstract] [Full-text]
13. Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death.
    Anticancer Drugs, 19(1): 45-54. [Abstract] [Full-text]
14. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
    J Clin Oncol, 25(34): 5442-7. [Abstract] [Full-text]

© 2004-2008 Acute Myeloid Leukemia Research Today. All Rights Reserved.